City Council Approves IDD for Fox Chase Cancer Center Expansion
PHILADELPHIA (Dec. 14, 2007)—Philadelphia City Council yesterday approved an IDD (Institutional Development District), one of two ordinances that will allow Fox Chase Cancer Center to expand into Burholme Park. The IDD provides for the development of a campus master plan for the proposed expansion. The second ordinance – the bill that would transfer the 19.5 acres under a long-term lease – was deferred until January to properly work through the final details.
"The IDD is an important step forward, but we will be pleased when a proper agreement is complete for the land transfer ordinance," said Robert C. Young, MD, Chancellor at Fox Chase Cancer Center. "While all parties have reached a consensus on the major components of the agreement, there are still important details to be worked out. We hope this postponement will be short and that it will allow time to reach a final agreement that meets the needs of everyone involved. This has been a lengthy process that has already had a significant impact on our ability to provide care for cancer patients in the area. We need to be able to develop and move forward with an expansion strategy."
The Fox Chase expansion is necessary to accommodate new cancer research and the growing number of cancer patients requiring care every year. In 1980, Fox Chase treated 800 new patients a year. In 2007, that number had grown to almost 7,000 new patients and is expected to double by 2015. The Center sees over 70,000 outpatients a year. Future phases of the planned expansion include a new state-of-the-art hospital, an outpatient treatment center and advanced research facilities as well as a new parking garage.
The Fairmount Park Commission originally approved the proposed lease in 2006. The agreement designates more than $1 million for Burholme Park improvements and an endowment fund; authorizes Fox Chase to make all lease payments directly to the Fairmount Park Conservancy; and ensures that parkland being leased will remain public until such time as the land is needed.
Fox Chase Cancer Center, part of Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase also was among the first institutions to receive the National Cancer Institute’s prestigious comprehensive cancer center designation in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are routinely recognized in national rankings, and the Center’s nursing program has achieved Magnet status for excellence three consecutive times. Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research and oversees programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX-CHASE (1-888-369-2427).